Early detection and mass screening for cancer.
The author reviews the evidence for the efficacy of early detection and mass screening programs in reducing morbidity and mortality from cancer. In cancer of the cervix, although screening reduces morbidity, we still do not have evidence for reduction in mortality. In cancer of the breast, one study suggests a reduction in mortality in the 50-59 year age group following screening by clinical examination and mammography. In other sites, especially lung, there is no evidence at present to support the adoption of mass screening programs. It is important that such programs should be carefully evaluated in the population, preferably in controlled studies.
Miller
A B
AB
Cancer. 1970 Jul;26(1):29-38
5424535
Br J Prev Soc Med. 1968 Jul;22(3):161-4
5664163
Aust N Z J Obstet Gynaecol. 1970 Feb;10(1):41-8
5269083
JAMA. 1971 Mar 15;215(11):1777-85
5107709
Br Med J. 1970 Nov 21;4(5733):461-3
5481219
Cancer. 1970 Oct;26(4):808-11
5506604
Geriatrics. 1971 Aug;26(8):130-5 passim
5096459
J Obstet Gynaecol Br Commonw. 1967 Aug;74(4):479-86
6033268
Cancer. 1970 Jan;25(1):113-20
5410302
Cancer. 1968 Dec;22(6):1108-19
5705772
Thorax. 1968 Jul;23(4):414-20
5664703
J Ont Dent Assoc. 1966 Dec;43(12):10-4
5226036
J Obstet Gynaecol Br Commonw. 1966 Jun;73(3):382-9
5911115
Proc Natl Acad Sci U S A. 1969 Sep;64(1):161-7
5262998
Cancer. 1969 Dec;24(6):1206-11
5353966
Br Med J. 1972 May 6;2(5809):316-7
5022040
J Obstet Gynaecol Br Commonw. 1968 Apr;75(4):392-404
5647704
Am Rev Respir Dis. 1968 Jul;98(1):75-86
5690506